Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

GRI Bio Inc (GRI)

  • SEC News
  • Dec. 12, 2025, 11:03 UTC
  • 2
  • 0 comments

New Form EFFECT - GRI Bio, Inc. Filed: 2025-12-11 AccNo: 9999999995-25-003687 Size: 1 KB

Comment Full text

Sol Gel Technologies Ltd (SINT)

  • SEC News
  • Dec. 12, 2025, 11:03 UTC
  • 2
  • 0 comments

New Form EFFECT - Sintx Technologies, Inc. Filed: 2025-12-11 AccNo: 9999999995-25-003662 Size: 1 KB

Comment Full text

Medicinova Inc (MNOV)

  • SEC News
  • Dec. 12, 2025, 11:03 UTC
  • 1
  • 0 comments

New Form EFFECT - MEDICINOVA INC Filed: 2025-12-11 AccNo: 9999999995-25-003685 Size: 1 KB

Comment Full text

So-Young International Inc (SY)

  • SEC News
  • Dec. 12, 2025, 11:01 UTC
  • 2
  • 1 comments

📋 Hui Nick Zhao (Officer) plans to sell 403K shares of So-Young International Inc. (at $3.11 each, total $1.3M) Filed: Dec 12, 2025 | ID: 120424

Comment Full text

West Pharmaceutical Services Inc (WST)

  • Business News
  • Dec. 12, 2025, 11:00 UTC
  • 2
  • 1 comments

West to Participate in Upcoming Investor Conference

Market reaction Comment Full text

Top Glove Corporation BHD (BVA)

  • SEC News
  • Dec. 12, 2025, 10:38 UTC
  • 2
  • 0 comments

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016

Comment Full text

Top Glove Corporation BHD (BVA)

  • SEC News
  • Dec. 12, 2025, 10:36 UTC
  • 2
  • 0 comments

General Announcement: CHANGES IN DIRECTORS INTEREST PURSUANT TO SECTION 219 OF THE COMPANIES ACT, 2016

Comment Full text

Top Glove Corporation BHD (BVA)

  • SEC News
  • Dec. 12, 2025, 10:36 UTC
  • 2
  • 0 comments

General Announcement: DEALINGS DURING CLOSED PERIOD

Comment Full text

Top Glove Corporation BHD (BVA)

  • SEC News
  • Dec. 12, 2025, 10:35 UTC
  • 2
  • 0 comments

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016

Comment Full text

FDA approves EPINEPHRINE from AMNEAL

  • FDA Approval
  • Dec. 12, 2025, 09:56 UTC
  • 6
  • 0 comments

Final approval of ANDA #ANDA #218208 for EPINEPHRINE. Decision date: 12/08/2025

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 12, 2025, 09:56 UTC
  • 3
  • 0 comments

Labeling changes approved for HIKMA. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 12/09/2025

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 12, 2025, 09:56 UTC
  • 4
  • 0 comments

Labeling changes approved for PHARM ASSOC. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 12/09/2025

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 12, 2025, 09:56 UTC
  • 5
  • 0 comments

Labeling changes approved for ANI PHARMS. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 12/09/2025

Comment Full text

Hyphens Pharma International Limited (1J5)

  • SEC News
  • Dec. 12, 2025, 09:44 UTC
  • 2
  • 0 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change of Directors Interest - Dr Tan Kia King

Comment Full text

IHH Healthcare Berhad (Q0F)

  • SEC News
  • Dec. 12, 2025, 09:34 UTC
  • 2
  • 0 comments

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Comment Full text
  • Previous
  • 61
  • 62
  • 63
  • 64
  • 65
  • Next

Search

News categories

  • Technical Exchange News(10572)
  • Event(1939)
  • SEC News(183621)
  • FDA Approval(9812)
  • Company Report(721)
  • Business News(121744)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin